Blood Transfusion Diagnostics Market

Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blood collected from the donor has to be screened for a number of infectious disease before transfusion. Thus, blood transfusion diagnostics play an important role in blood transfusion in order to avoid infection to both the receiver and healthcare staff.

Blood Transfusion Diagnostics Market contains market size and forecasts of Blood Transfusion Diagnostics in Global, including the following market information:

Global Blood Transfusion Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Blood Transfusion Diagnostics market was valued at 3122.6 million in 2021 and is projected to reach US$ 4276.1 million by 2028, at a CAGR of 4.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ELISA Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Blood Transfusion Diagnostics include Grifols, Thermo Fisher Scientific, Roche, bioM?rieux, Bio-Rad, Ortho Clinical Diagnostics, Becton Dickinson, Fujirebio and DiaSorin(American Standard Companies), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Blood Transfusion Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Blood Transfusion Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Blood Transfusion Diagnostics Market Segment Percentages, by Type, 2021 (%)

ELISA

NAT

Western Blot Assays

Fluorescence Assay

Other Technology

Global Blood Transfusion Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Blood Transfusion Diagnostics Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Blood Banks

Laboratories

Other

Global Blood Transfusion Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Blood Transfusion Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Blood Transfusion Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Blood Transfusion Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Grifols

Thermo Fisher Scientific

Roche

bioM?rieux

Bio-Rad

Ortho Clinical Diagnostics

Becton Dickinson

Fujirebio

DiaSorin(American Standard Companies)

Beckman Coulter

Diagast

Abbott

BAG Health Care

Quidel